NASDAQ: BMRABiomerica Inc Stock Ownership - Who owns Biomerica?
Insider buying vs selling
Have Biomerica Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Allen Barbieri | VChair | 2026-08-26 | 20,000 | $1.60 | $32.00kBuy |
| Eric Chin | Director | 2026-08-26 | 6,250 | $1.60 | $10.00kBuy |
| Zackary S. Irani | CEO | 2026-08-26 | 31,250 | $1.60 | $50.00kBuy |
| David Moatazedi | Director | 2026-08-26 | 10,000 | $1.60 | $16.00kBuy |
| M. Huff Gary | Director | 2026-08-20 | 31,250 | $1.60 | $50.00kBuy |
BMRA insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when BMRA insiders and whales buy or sell their stock.
BMRA Shareholders
What type of owners hold Biomerica Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Janet Moore | 56.77% | 2,605,228 | $6.04M | Insider |
| Janet Trust Dtd 8. Moore | 13.86% | 635,977 | $1.48M | Insider |
| The Broadoak Fund | 10.90% | 500,000 | $1.16M | Insider |
| William Snider | 10.90% | 500,000 | $1.16M | Insider |
| Brc Group Holdings Inc | 10.03% | 460,080 | $1.07M | Insider |
| Zackary S. Irani | 5.29% | 242,570 | $562.76k | Insider |
| Jane Emerson | 3.40% | 156,000 | $361.92k | Insider |
| Francis Cano | 3.33% | 152,636 | $354.12k | Insider |
| Catherine Coste | 3.00% | 137,890 | $319.90k | Insider |
| Francis E. Capitanio | 1.90% | 87,000 | $201.84k | Insider |
BMRA vs Medical Device Stocks
Biomerica Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.